Ruxolitinib Versus Best Available Therapy in Patients with Essential Thrombocythemia: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

Authors :: Steffen Koschmieder
Susanne Isfort
Florian H. Heidel
Andreas Hochhaus
Heiko Becker
Philipp J. Jost
Philippe Schafhausen
Martin Griesshammer
Denise Wolleschak
Mathias Haenel
Joachim R Göthert
Lino L. Teichmann
Katja Sockel
Markus P. Radsak
Andreas Reiter
Konstanze Döhner
Sebastian Balleisen
Nadja Jaekel
Nikolas von Bubnoff
Frank Stegelmann
Deniz Gezer
Maike Kortmann
Julia Frank
Martin Hellmich
Tim H. Brümmendorf
Source :: Blood. 140:1790-1793
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Tools